Latest Nura Bio News & Updates

See the latest news and media coverage for Nura Bio. We track all announcements, press releases, and industry mentions in real time, all in one place.

Nura Bio

Neuroprotective drug developer

nurabio.com

Headquarters: South San Francisco, United States
Founded year: 2018
Company type: Private company
Number of employees: 35–50
Industry: Biotechnology & Medical Research

Last updated June 22

Latest news about Nura Bio

In short: Nura Bio raised $73.8M in Series B financing and dosed its first ALS patient.

Company announcements

June 22 Nura Bio

Nura Bio completes $73.8M Series B financing

The funding will advance SARM1 inhibitor programs, with first patient dosed in ALS study.

February 18, 2025 Nura Bio

Nura Bio appoints C-suite executives

Lahar Mehta, M.D. as Chief Medical Officer and Scott Greenberg as Chief Business Officer to advance clinical pipeline.

September 16, 2024 Nura Bio

Nura Bio closes Series A financing with $68M

Total raised exceeds $140M. Appoints Shilpa Sambashivan as CEO. Completes Phase 1 of NB-4746.

August 25, 2023 Nura Bio

Nura Bio initiates Phase 1 trial for NB-4746

NB-4746 is an oral, brain-penetrant SARM1 inhibitor for neurological diseases like ALS and MS. This marks Nura Bio's transition to a clinical-stage company.

Media coverage

June 22 The Manila Times

Nura Bio Completes $73.8M Series B Financing and Advances Pipeline of SARM1 Inhibitors

The financing, led by The Column Group, with participation from Euclidean Capital, Samsara BioCapital, and Sanofi Ventures, will fund the development of Nura Bio’s clinical...

September 17, 2024 MedCity News

Neuro Startup Nura Bio Adds $68M to Spare Axons With Its Brain-Penetrating Drug

Neurodegenerative disorders progress in a variety of ways, but one characteristic many of them share is the breakdown of axons, a cable-like fiber that extends...

February 2, 2024 Healio

Nura Bio announces phase 1 study for oral, brain-penetrant SARM1 inhibitor

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A Bay Area-based biopharmaceutical...

February 2, 2023 BioWorld

Nura Bio presents new SARM1 inhibitors for neurological disorders

BioWorld - Monday, October 7, 2024 Breaking News: BioWorld celebrates nine wins at 2024 APEX Awards See today's BioWorld Science Home » Nura Bio presents...

Never miss news about Nura Bio

Track Nura Bio and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Nura Bio competitors & trending companies

Browse news for competitors to Nura Bio and other trending companies.